Metabolic Flexibility in NYC: The Longevity Marker Most Patients Have Never Been Tested For

Most people are told their metabolism is either "fast" or "slow." That framing is nearly useless in clinic. A far more informative question is whether your metabolism is flexible — whether your cells can switch cleanly between burning carbohydrate and burning fat depending on what you have eaten and what you are doing.

Metabolic flexibility is one of the most underrated markers of healthy aging. It sits upstream of energy levels, body composition, cardiovascular risk, cognitive stability, and how well you tolerate a bad night of sleep or a long travel day. At Regen Health Physicians, Dr. Ajit Dhaliwal evaluates metabolic flexibility in patients across New York City and Salt Lake City as part of a broader longevity and chronic disease workup — because when it is impaired, almost everything else you are trying to optimize gets harder.

What metabolic flexibility actually means

Your body runs on two primary fuels: glucose (from carbohydrate and stored glycogen) and fatty acids (from dietary fat and adipose tissue). A metabolically flexible person shifts between them without drama:

• After a carbohydrate-containing meal, insulin rises, glucose uptake into muscle increases, fat oxidation is suppressed, and blood sugar returns to baseline within about two hours.
• During fasting or steady low-intensity activity, insulin falls, fat is released from adipose tissue, and mitochondria oxidize fatty acids and ketones efficiently.
• During hard exercise, the system shifts back toward glycolysis quickly to meet power demands.

The concept was formalized in research by Kelley and Mandarino, who observed that lean, insulin-sensitive individuals show a large swing in respiratory quotient (RQ) between fasted and fed states, while individuals with obesity and type 2 diabetes show a blunted swing — a state described as metabolic inflexibility. The muscle stays stuck in a partial, inefficient fuel-burning pattern regardless of what is available.

Why the "stuck" state matters

Metabolic inflexibility is not simply a consequence of insulin resistance; it appears to travel with it and often precedes an abnormal fasting glucose. Incompletely oxidized fatty acid intermediates — diacylglycerols, ceramides, acylcarnitines — accumulate inside muscle and liver cells and interfere with insulin signaling. That produces a self-reinforcing loop: impaired fuel switching drives insulin resistance, and insulin resistance further impairs fuel switching.

Clinically, this is why patients with a "normal" fasting glucose of 95 mg/dL can still be years into a metabolic problem. Standard screening looks at a single fasted snapshot; flexibility is about the transitions.

Symptoms patients actually report

Metabolic inflexibility rarely announces itself with a lab value. It shows up as pattern-based symptoms:

• Energy crashes 60–120 minutes after meals, especially carbohydrate-heavy lunches
• Inability to go 4–5 hours without eating without irritability, shakiness, or brain fog
• Waking at 2–4 a.m., often tied to nocturnal glucose swings and a compensatory cortisol/adrenaline surge
• Needing carbohydrate to train, with poor endurance at easy paces despite adequate fitness
• Weight that responds poorly to calorie restriction, with disproportionate loss of energy rather than fat
• Post-travel or post-poor-sleep glucose instability that lingers for days

None of these are diagnostic on their own. Together, in a patient with an expanding waistline and a rising triglyceride-to-HDL ratio, they form a recognizable picture.

How we measure it

There is no single blood test for metabolic flexibility. We build the picture from several angles.

Fasted laboratory markers

• Fasting insulin — often the earliest abnormality. We look for values in the low single digits (µIU/mL); results in the teens with normal glucose suggest compensated insulin resistance.
• HOMA-IR, calculated from fasting glucose and insulin, to quantify that compensation.
• HbA1c for a 3-month glycemic average, interpreted alongside red cell turnover (anemia and high turnover can falsely lower it).
• Triglyceride:HDL ratio — a practical surrogate for insulin sensitivity in most populations.
• ALT and hepatic imaging when indicated, since fatty liver frequently accompanies inflexibility.
• Apolipoprotein B and Lp(a) to characterize cardiovascular risk that often travels with the metabolic picture.

Dynamic testing

Because the problem is about transitions, dynamic data is more informative than any fasted value:

• Oral glucose tolerance test with paired insulin levels at 0, 30, 60, and 120 minutes. A large 30- or 60-minute insulin spike with normal glucose is one of the clearest early signals.
• Continuous glucose monitoring (CGM) for 10–14 days in a non-diabetic patient. We are not chasing a perfectly flat line; we look at post-meal peak height, time to return to baseline, overnight stability, and how the same meal behaves after good versus poor sleep.
• Substrate oxidation testing (indirect calorimetry, where available) to measure the actual RQ swing between fasted and fed states.

Functional and body-composition context

Muscle is the largest site of glucose disposal in the body, so we assess lean mass, grip strength, and — when relevant — VO2 max or a simple submaximal aerobic benchmark. Two people with the same HbA1c and very different muscle mass do not have the same prognosis.

Why flexibility declines with age

Several mechanisms converge, and they are largely modifiable:

1. Mitochondrial density and quality fall. Fewer, less efficient mitochondria mean less capacity for fat oxidation. Mitochondrial turnover (fission, fusion, mitophagy) also becomes less responsive with age.
2. Muscle mass declines. Sarcopenia removes the primary glucose sink, pushing more of the post-meal load onto liver and adipose tissue.
3. Physical activity becomes more monotonous. Modern schedules produce a narrow band of intensity — neither long, easy aerobic work nor genuinely hard efforts — and both ends of the range drive mitochondrial adaptation.
4. Sleep and circadian disruption. Even a few nights of restricted sleep reduce insulin sensitivity measurably in healthy volunteers. Late-night eating puts a glucose load into the least insulin-sensitive part of the circadian cycle.
5. Hormonal change. Falling estrogen in perimenopause and falling testosterone in men both shift body composition and insulin sensitivity unfavorably. This is one reason a metabolic workup and a hormone evaluation often belong together.
6. Chronic low-grade inflammation and visceral fat, which directly impair insulin signaling.

Restoring metabolic flexibility: what the protocol looks like

The interventions are not exotic. What matters is sequencing, dosing, and measuring.

1. Build the aerobic base

Low-intensity aerobic work — conversational-pace zone 2 — is the most direct stimulus for mitochondrial biogenesis and fat-oxidation capacity. We typically target 150–210 minutes per week across 3–4 sessions, built gradually. Patients frequently discover their "easy" pace is not easy at all, which is itself diagnostic.

2. Add resistance training

Two to three sessions per week of progressive resistance training expands the glucose disposal reservoir and improves insulin sensitivity independent of weight loss. For older patients and anyone with joint limitations, we coordinate programming with our regenerative orthopedic care so that knee, shoulder, or back pain does not become the reason training stops.

3. Restructure meal timing before restricting food

Most patients improve substantially by changing when they eat before changing much about what they eat:

• Finish the last meal 3 hours before bed
• Keep a consistent 10–12 hour eating window rather than an aggressive fast
• Front-load protein at breakfast (30–40 g) to reduce later-day glucose variability
• Place carbohydrate around training sessions rather than at the evening meal

Aggressive extended fasting is not a first-line tool for patients with low muscle mass, disordered eating history, or high stress load.

4. Improve post-meal glucose handling

A 10–15 minute walk after the largest meal of the day reliably lowers the post-meal glucose excursion. Eating protein and vegetables before starch, and improving fiber intake to 30+ g/day, both blunt peaks. These are small levers with visible CGM effects within days.

5. Treat sleep as a metabolic intervention

Untreated obstructive sleep apnea can make every other intervention underperform. If a patient snores, has witnessed apneas, a thick neck, or morning headaches, we test before we optimize anything else.

6. Targeted therapies when indicated

Where lifestyle work has been executed properly and the picture remains impaired, we consider adjuncts:

• [Peptide therapy](/peptides) — mitochondrial and metabolic peptides such as MOTS-c, and growth-hormone secretagogues where appropriate, used as adjuncts with monitoring rather than as substitutes for training.
• GLP-1 receptor agonists in patients meeting clinical criteria, paired mandatorily with resistance training and adequate protein to protect lean mass.
• Metformin in selected patients with documented insulin resistance, with the caveat that it can blunt some training adaptations.
• Hormone optimization where deficiency is confirmed on repeat testing.

Nothing here is prescribed off a symptom list alone. Each is chosen against labs, dynamic data, and a specific goal, then re-measured.

A realistic timeline

• Weeks 1–4: Post-meal energy crashes soften; overnight glucose stabilizes; sleep improves. Little visible weight change.
• Weeks 6–12: Fasting insulin and triglyceride:HDL begin to move. Easy-pace aerobic work feels genuinely easy. Hunger becomes less urgent between meals.
• Months 3–6: HbA1c shifts, body composition changes become obvious, and CGM curves flatten. This is when we repeat the dynamic testing.
• Months 6–12: Consolidation. The goal is a metabolism that tolerates a disrupted week — travel, a bad night, a heavy dinner — and returns to baseline quickly.

Patients who stall usually stall for one of three reasons: undertrained aerobic base, insufficient protein and resistance work, or an untreated sleep disorder.

Where this fits in a longevity plan

Metabolic flexibility is a leverage point because it sits underneath so many other outcomes. Insulin resistance is implicated in cardiovascular disease, non-alcoholic fatty liver disease, several cancers, and cognitive decline. Improving fuel switching does not guarantee any particular outcome, but it removes a persistent headwind — and it makes the rest of a longevity and preventive care plan measurably more effective.

It is also one of the few areas where patients can see their own physiology change in near real time. A two-week CGM wear, repeated three months into a protocol, is often more motivating than any lecture.

Working with us in NYC and Salt Lake City

Dr. Dhaliwal's metabolic evaluations combine advanced fasted labs, dynamic insulin and glucose testing, CGM interpretation, body composition, and a review of sleep, training, and hormonal status. From there we build a staged protocol and re-measure rather than guess. Many components — lab review, CGM interpretation, protocol adjustments — can be handled virtually, with in-person visits for procedures and physical assessment.

If you recognize the afternoon crashes, the 3 a.m. wake-ups, or the sense that your body no longer handles food the way it used to, that is worth investigating properly. Book a consultation to start with real data.

---

Medical disclaimer: This article is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Continuous glucose monitoring, peptide therapy, GLP-1 medications, metformin, and hormone therapy require individualized evaluation and physician supervision. Do not start, stop, or change any medication or fasting protocol without consulting a qualified physician. Individual results vary.